Trials / Conditions / Medulloblastoma Recurrent

Medulloblastoma Recurrent

12 registered clinical trials studyying Medulloblastoma Recurrent — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	B7-H3.CD28Z.CART in CNS Neoplasms NCT07390539	Robbie Majzner	Phase 1
Not Yet Recruiting	Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease NCT07346157	Sabine Mueller, MD, PhD	Phase 1 / Phase 2
Recruiting	Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study NCT07242963	Mohammad H. Abu Arja	—
Not Yet Recruiting	A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressiv NCT07017816	Children's National Research Institute	EARLY_Phase 1
Recruiting	Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for NCT06607692	Fundación de investigación HM	Phase 1 / Phase 2
Recruiting	Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma NCT05057702	University of California, San Francisco	N/A
Recruiting	HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors NCT03911388	M.D. Anderson Cancer Center	Phase 1
Completed	Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescen NCT04023669	St. Jude Children's Research Hospital	Phase 1
Terminated	Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not H NCT03904862	Pediatric Brain Tumor Consortium	Phase 1 / Phase 2
Completed	Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Gli NCT03615404	Gary Archer Ph.D.	Phase 1
Completed	Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT NCT02962167	Sabine Mueller, MD, PhD	Phase 1
Recruiting	Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors NCT01356290	Medical University of Vienna	Phase 2